Christine Pellizzari
2020 - INSMED
In 2020, Christine Pellizzari earned a total compensation of $3.2M as Chief Legal Officer at INSMED, a 19% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $245,300 |
---|---|
Option Awards | $1,875,065 |
Salary | $476,150 |
Stock Awards | $624,981 |
Other | $11,400 |
Total | $3,232,896 |
Pellizzari received $1.9M in option awards, accounting for 58% of the total pay in 2020.
Pellizzari also received $245.3K in non-equity incentive plan, $476.2K in salary, $625K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Christine Pellizzari's compensation ranked 3,603rd out of 13,090 executives tracked by ExecPay. In other words, Pellizzari earned more than 72.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,603 | 73rd |
Manufacturing | 1,408 | 75th |
Chemicals And Allied Products | 527 | 77th |
Drugs | 457 | 77th |
Pharmaceutical Preparations | 343 | 77th |
Pellizzari's colleagues
We found five more compensation records of executives who worked with Christine Pellizzari at INSMED in 2020.
News
Science 37 Holdings CEO David Coman's 2022 pay slips 4% to $8.1M
March 20, 2023
Science 37 Holdings CEO David Coman's 2021 pay jumps 656% to $8.4M
March 23, 2022
INSMED CEO William Lewis' 2020 pay slips 14% to $6.2M
April 1, 2021
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019